510(k) Report

510(k) · Cleared

Cleared

ARC-EX System

K251821510(k) TraditionalCleared Nov 14, 2025154-day reviewClass II21 CFR 890.5851

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Onward Medical, Inc. · SDO Transcutaneous Electrical Spine Stimulator To Improve Skeletal Muscle Strength And Sensation

Cleared on Nov 14, 2025 as substantially equivalent to DEN240014 (Onward Medical, Inc., 2024) after a 154-day review. Its family tree reaches back 1 generation to 2024.

Decided
Nov 14, 2025
Review
154 days
Class
Class II
Product code
SDO
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to DEN240014 (2024). No later device cites it as a predicate yet.

DEN240014 · ARC-EX System · Onward Medical, Inc. · 20242020202220242026
DEN240014 · ARC-EX System · Onward Medical, Inc. · 20240
  1. Root · 1 generation backDEN240014 ARC-EX SystemOnward Medical, Inc. · 2024
  2. This deviceK251821 ARC-EX SystemOnward Medical, Inc. · 2025
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1DEN240014ARC-EX SystemOnward Medical, Inc.2024—
0 (this device)K251821ARC-EX SystemOnward Medical, Inc.2025—
FIG. 1 — Lineage of K251821, 2024–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in SDO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new SDO device

  1. #1 K253638 xStep (xStep)score 11.2 · 1 generation · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*DEN240014ARC-EX System
Summary page 5
….92(a)(3) Predicate # Predicate Trade Name (Primary Predicate is listed first) Product Code I DEN240014 11 ARC-EX System…
Onward Medical, Inc.2024—

Also cleared against DEN240014: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • 2 other devices also cite its predicate DEN240014.

How does its category compare?

All SDO devices

SDO Transcutaneous Electrical Spine Stimulator To Improve Skeletal Muscle Strength And Sensation: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.

FDA decisions per year · SDO

2so far in 2026, the most since 2007

2024: 12025: 12026 (partial year): 2
2007high 2 (2026) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · SDO

Too few SDO 510(k)s in any year since 2007 to give a median.

Recalls per year · SDO

No recall names SDO since 2007.

Adverse event reports per year · SDO

No MAUDE report names SDO since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20230—00
20241—00
20251—00
20262—0—

What is it indicated for?

The ARC-EX System is intended to deliver programmed transcutaneous electrical spinal cord stimulation

in conjunction with functional task practice in the clinic and with take-home exercises in the home to

improve hand sensation and strength in individuals between 18 and 75 years old that present with a

chronic, non-progressive neurological deficit resulting from an incomplete spinal cord injury (C2-C8

inclusive).

The ARC-EX System is intended to be operated in medical centers by Rehabilitation Professionals and at

home by Patients and Persons Providing Assistance to the Patient as needed.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K251821: ARC-EX System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K251821

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026